Researchers have discovered that lung cancer cells are able to utilize lactate as an energy source to facilitate growing. This finding challenges the previous understanding of cancer metabolism and may have implications for future cancer research.
Browsing: cellular metabolism
Proof-of-concept research seeks to reduce glioblastoma drug toxicity through improved BBB delivery.
Study highlights a unique survival mechanism in nutrient-starved pancreatic cancer cells, revealing a potential new therapeutic angle.
Researchers demonstrate that malignant glioma cells rely on fats for growth, rather than sugars, indicating a new target for therapeutic agents.
Differences in metabolic pathways in castration resistant prostate cancer and androgen-dependent prostate cancer may lead to new therapies
New preclinical research highlights the metabolic differences between castration resistant prostate cancer and androgen-dependent prostate cancer and the resultant possibilities for treatment.
Abnormal metabolism of the essential amino acids methionine and tryptophan has been defined in glioblastoma, hinting at novel strategies for the development of therapies in the disease.
Preclinical study indicates that CDK4/6 inhibitors alter the metabolism of pancreatic cancer cells.
A new study has highlighted a potential method of targeting the metabolic pathway in order to boost the anticancer activity of T cells.
A novel combination of nontoxic ketogenic diet, ketogenic supplements and hyperbaric oxygen therapy doubled survival time in a mouse model of metastatic cancer.
A recent study from the University of Colorado Cancer Center has yielded early evidence of genetic differences between CRC in young and older patients.